EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies.

2020

https://researcherprofiles.org/profile/117442078

Nick Barkham, Georg Schett, Xenofon Baraliakos, Filip van den Bosch, Atul Deodhar, Lianne S Gensler, Mikkel ?stergaard, Shital Agawane, Ayan Das Gupta, Shephard Mpofu, Todd Fox, Adam Winseck, Abhijit Shete, Brian Porter

Center for Advancing Scholarship in Education

Center for Faculty Educators

EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies.